As of Apr 24
| +0.33 / +1.76%|
The 6 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 19.00, with a high estimate of 24.00 and a low estimate of 15.00. The median estimate represents a -0.68% decrease from the last price of 19.13.
The current consensus among 8 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.